Advances in Peri-Operative Therapy in Bladder and Kidney Cancer - SPOC

A comprehensive overview of past, present, and future management of systemic therapy for muscle-invasive bladder cancer and renal cell carcinoma. Includes updates on neoadjuvant and adjuvant therapy, as well as organ preservation techniques.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.

Learning Objectives

  • Recognize indications for neoadjuvant therapy for muscle-invasive bladder cancer and appropriate regimens
  • Discuss options for adjuvant therapy for high-risk bladder cancer
  • Describe options for adjuvant therapy in renal cell carcinoma, including VEGF TKI therapy and immune checkpoint inhibition

 

Taking the Course

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at [email protected] or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
07/01/2022
Course expires: 
06/30/2023
Photo of Tracy L. Rose, MD, MPH 

Tracy L. Rose, MD, MPH

Assistant Professor of Medicine
Division of Oncology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

 

This Non-Credit Course does not have accreditation. It only offers general participation certificates.

Available Credit

  • 1.00 Participation
Please login or register to take this course.